Jan Hillson - 01 Jul 2021 Form 3 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Jan Hillson
Issuer symbol
ELDN
Transactions as of
01 Jul 2021
Net transactions value
$0
Form type
3
Filing time
09 Jul 2021, 20:09:54 UTC
Next filing
02 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ELDN Stock Option (Right to Buy) 01 Jul 2021 Common Stock 40,000 $7.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase up to 40,000 shares of Common Stock, which option vests with respect to 20,000 shares on July 1, 2022 and with respect to 20,000 shares on July 1, 2023.

Remarks:

Ex. 24 - Power of Attorney